Tag Archive for: betibeglogene autotemcel

The biotech company is looking to forge a path to profitability by scaling up the commercial uptake of Zynteglo and winning the FDA’s approval for its lovo-cel gene therapy for sickle cell disease.

End-to-end vector manufacturing optimizes batch success and delivers more doses at lower cost.